UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH RESTRICTION
|
|
- Charla Fields
- 5 years ago
- Views:
Transcription
1 UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH RESTRICTION Eduard Gratacos Servicio de Medicina Maternofetal Hospital Clinic y Hospital Sant Joan de Deu - Universidad de Barcelona
2 1. Identify small fetus 2. FGR vs. SGA 3. Early vs. Late 4. Stage-based management protocol
3 1. Identify small fetus 2. FGR vs. SGA 3. Early vs. Late 4. Stage-based management protocol
4 Neonatal and Fetal GA-adjusted normal weight in the same population
5 Neonatal and Fetal GA-adjusted normal weight in the same population
6 1. Identify small fetus 2. FGR vs. SGA 3. Early vs. Late 4. Stage-based management protocol
7 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes
8 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes Poor perinatal outcome + IUFD (Doppler) Signs of adaptation
9 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes Poor perinatal outcome + IUFD (Doppler) Signs of adaptation Perinatal outcome normal - No IUFD NO signs of adaptation
10 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes Poor perinatal outcome + IUFD (Doppler) Signs of adaptation IUGR Placental insufficiency Perinatal outcome normal - No IUFD NO signs of adaptation SGA Unknown (constitutional + others)
11 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes Poor perinatal outcome + IUFD (Doppler) Signs of adaptation IUGR Placental insufficiency Perinatal outcome normal - No IUFD NO signs of adaptation SGA Unknown (constitutional + others)
12 Exclude primary fetal defect Exclude extrinsic cause ISOLATED FETAL SMALLNESS = POORER PROGNOSIS Perinatal and Long-term Outcomes Poor perinatal outcome + IUFD (Doppler) Signs of adaptation IUGR Placental insufficiency Perinatal outcome normal - No IUFD NO signs of adaptation SGA Unknown (constitutional + others) FGR vs. SGA: DIFFERENT MANAGEMENT
13 The discovery of UA and hemodynamics of IUGR Constitutionally small Placental insufficiency Extrinsic cause Primary fetal defect SGA FGR
14 The discovery of UA and hemodynamics of IUGR Constitutionally small Placental insufficiency Extrinsic cause Primary fetal defect SGA FGR N cases 0 N cases
15 The discovery of UA and hemodynamics of IUGR Constitutionally small Placental insufficiency Extrinsic cause Primary fetal defect SGA FGR N cases UA Doppler + (EARLY-ONSET) 0 N cases
16 The discovery of UA and hemodynamics of IUGR Constitutionally small Placental insufficiency Extrinsic cause Primary fetal defect SGA FGR N cases UA Doppler + (EARLY-ONSET) 0 UA Doppler N (LATE-ONSET) N cases Savchev 2013
17 The discovery of UA and hemodynamics of IUGR Constitutionally small Placental insufficiency Extrinsic cause Primary fetal defect SGA FGR N cases UA Doppler + (EARLY-ONSET) 0 UA Doppler N (LATE-ONSET) N cases Savchev 2013 FGR = abnormal UA Doppler
18 SGA: proportion of perinatal adverse outcomes in 376 consecutive cases % Neonatal acidosis CS for distress Abnormal NBAS Any Figueras 2011
19 50% 45% IMPACT OF NON- DETECTED IUGR ON LATE FETAL MORTALITY Hospital Clínic Barcelona % 30% 20% 10% 30% 25% 0% FGR Unknown Others Relevant Condition ReCoDe
20 50% 45% IMPACT OF NON- DETECTED IUGR ON LATE FETAL MORTALITY Hospital Clínic Barcelona % 30% 20% 10% 30% 25% 0% FGR Unknown Others Relevant Condition ReCoDe Impact of growth restriction in late pregnancy stillbirth Gardosi et al. BMJ 2005, 2013 N=2625 stillbirths FGR as relevant condition identified in 43-60%
21 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls Figueras 2012
22 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls Figueras 2012
23 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls 50% 40% 30% 20% 10% 0% Controls All normal Any abnormal Figueras 2012
24 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls 50% 40% 30% 20% 10% 8% 0% Controls All normal Any abnormal Figueras 2012
25 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls 50% 40% 30% 20% 10% 8% 11% 0% Controls All normal Any abnormal Figueras 2012
26 Prognostic criteria of poor outcome -SGA CS for distress and/or neonatal acidosis UtA >p95 CPR <p5 EFW CENTILE <3 N=447 SGA controls 50% 40% 40% 30% % 20% 10% 8% 11% 0% Controls All normal Any abnormal Figueras 2012
27 Distribution of cases when IUGR = abnormal UA Doppler Savchev 2013
28 Distribution of cases when IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
29 1. Identify small fetus 2. FGR vs. SGA 3. Early vs. Late 4. Stage-based management protocol
30 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR
31 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR
32 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%)
33 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT PROBLEM: DIAGNOSIS
34 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT Placental disease: high (UA+, PE high) PROBLEM: DIAGNOSIS Placental disease: low (UA-, PE low)
35 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT Placental disease: high (UA+, PE high) Hypoxia ++: systemic CV adaptation PROBLEM: DIAGNOSIS Placental disease: low (UA-, PE low) Hypoxia +/-: central CV adaptation
36 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT Placental disease: high (UA+, PE high) Hypoxia ++: systemic CV adaptation Tolerance to hypoxia. Natural history PROBLEM: DIAGNOSIS Placental disease: low (UA-, PE low) Hypoxia +/-: central CV adaptation Low tolerance: no natural history
37 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT Placental disease: high (UA+, PE high) Hypoxia ++: systemic CV adaptation Tolerance to hypoxia. Natural history High mortality and morbidity PROBLEM: DIAGNOSIS Placental disease: low (UA-, PE low) Hypoxia +/-: central CV adaptation Low tolerance: no natural history Low mortality but poor long outcome.
38 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth CTG ABNORMAL Systolic cardiac failure
39 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG ABNORMAL Systolic cardiac failure
40 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance UTERINE A. >p95 CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG ABNORMAL Systolic cardiac failure
41 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance UTERINE A. >p95 CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- cctg: reduced short-term variability CTG ABNORMAL Systolic cardiac failure
42 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance UTERINE A. >p95 CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 Ao ISTHMUS >p95 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- cctg: reduced short-term variability CTG ABNORMAL Systolic cardiac failure
43 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG / BPP ABNORMAL Systolic cardiac failure
44 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG / BPP ABNORMAL Systolic cardiac failure
45 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG / BPP ABNORMAL Systolic cardiac failure
46 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 cardiac ischemia Diastolic failure growth DUCTUS VENOSUS >p95 and a- CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation Systolic cardiac failure
47 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 growth CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation
48 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE COMPENSATED HYPOXIA DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental minimal tolerance to hypoxia impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 growth CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation
49 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental minimal tolerance to hypoxia impedance Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 growth CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation
50 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental minimal tolerance to hypoxia impedance UTERINE A. >p95 Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 growth CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation
51 FETAL DETERIORATION IN PLACENTAL INSUFFICIENCY EARLY VS LATE IUGR (>34s) PLACENTAL DISEASE DECOMPENSATED HYPOXIA SERIOUS INJURY DEATH Increment placental minimal tolerance to hypoxia impedance UTERINE A. >p95 Placental injury <30% CPR <p5 UMBILICAL A. >p95 Centralization MIDDLE CEREBRAL A. <p5 Ao ISTHMUS >p95 growth CTG / BPP ABNORMAL mild hypoxia no cardiovascular adaptation
52 IUGR= low CPR or high UtA or EFW<p3 or low PlGF 6 % SGA? 3 IUGR EARLY IUGR (1%) LATE IUGR (5-7%) PROBLEM: MANAGEMENT Placental disease: high (UA+, PE high) Hypoxia ++: systemic CV adaptation Tolerance to hypoxia. Natural history High mortality and morbidity PROBLEM: DIAGNOSIS Placental disease: low (UA-, PE low) Hypoxia +/-: central CV adaptation Low tolerance: no natural history Low mortality but poor long outcome.
53 1. Identify small fetus 2. FGR vs. SGA 3. Early vs. Late 4. Stage-based management protocol
54 IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
55 IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
56 IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
57 IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
58 IUGR = abnormal CPR or UtA or EFW<p3 Savchev 2013
59 RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH Increment placental impedance Centralization cardiac Diastoli Stage fetal deterioration II III IV V Systolic cardiac failure Risks of prematurity LOW MODERATE HIGH Red Line LATE IUGR Red Line EARLY IUGR
60 RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH Increment placental impedance Centralization cardiac Diastoli cctg: reduced STV Stage fetal deterioration II III IV V Systolic cardiac failure Risks of prematurity LOW MODERATE HIGH Red Line LATE IUGR Red Line EARLY IUGR
61 RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH Diagnostic/chronic markers Early and Late IUGR Increment placental impedance Centralization cardiac Diastoli cctg: reduced STV Stage fetal deterioration II III IV V Systolic cardiac failure Risks of prematurity LOW MODERATE HIGH Red Line LATE IUGR Red Line EARLY IUGR
62 RATIONALE FOR A STAGE-BASED APPROACH TO THE MANAGEMENT OF FGR PLACENTAL DISEASE HYPOXIA ACIDOSIS SERIOUS INJURY DEATH Diagnostic/chronic markers Early and Late IUGR Increment placental impedance Prognostic/Acute markers Early IUGR Centralization cardiac Diastoli cctg: reduced STV Stage fetal deterioration II III IV V Systolic cardiac failure Risks of prematurity LOW MODERATE HIGH Red Line LATE IUGR Red Line EARLY IUGR
63 Protocolo CIR Primer paso: si todo N = PEG I Doppler normal pero PFE<p3 II Aumento resistencia placentaria o redistribución inicial III Aumento grave resistencia y/o redistribución grave IV Alteración hemodinámica grave V Alto riesgo de muerte
64 Protocolo CIR Primer paso: si todo N = PEG I Doppler normal pero PFE<p3 II Aumento resistencia placentaria o redistribución inicial CPR <p5 Ut A >p95 MCA <p5 III Aumento grave resistencia y/o redistribución grave IV Alteración hemodinámica grave V Alto riesgo de muerte
65 Protocolo CIR Primer paso: si todo N = PEG I Doppler normal pero PFE<p3 II Aumento resistencia placentaria o redistribución inicial CPR <p5 Ut A >p95 MCA <p5 III Aumento grave resistencia y/o redistribución grave AEDV AoI >p95 IV Alteración hemodinámica grave V Alto riesgo de muerte
66 Protocolo CIR Primer paso: si todo N = PEG I Doppler normal pero PFE<p3 II Aumento resistencia placentaria o redistribución inicial CPR <p5 Ut A >p95 MCA <p5 III Aumento grave resistencia y/o redistribución grave AEDV AoI >p95 IV Alteración hemodinámica grave DV >p95 REDV UVpuls V Alto riesgo de muerte
67 Protocolo CIR Primer paso: si todo N = PEG I Doppler normal pero PFE<p3 II Aumento resistencia placentaria o redistribución inicial CPR <p5 Ut A >p95 MCA <p5 III Aumento grave resistencia y/o redistribución grave AEDV AoI >p95 IV Alteración hemodinámica grave DV >p95 REDV UVpuls V Alto riesgo de muerte DV (a rev) CGT decelerations of reduced short-term variability
68 IUGR Management protocol according to severity stages Stage V IV III II I Follow- up Daily 1-2 d 2/w 1/w Delivery DV(a- ) cctg abn. CTG dec. DV>p95 UV puls REDV (a) AEDV (b) AoI>95 Mode CS CS CS or LI LI EFW<p3 CPR>p95 UtA>p95 MCA<p5 <26w Mort. >90% 50% <10% Morb. >90% 50%
69 IUGR Management protocol according to severity stages Stage V IV III II I Follow- up Daily 1-2 d 2/w 1/w Delivery DV(a- ) cctg abn. CTG dec. DV>p95 UV puls REDV (a) AEDV (b) AoI>95 Mode CS CS CS or LI LI EFW<p3 CPR>p95 UtA>p95 MCA<p5 <26w Mort. >90% 50% <10% Morb. >90% 50%
70 IUGR Management protocol according to severity stages Stage V IV III II I Follow- up Daily 1-2 d 2/w 1/w Delivery DV(a- ) cctg abn. CTG dec. DV>p95 UV puls REDV (a) AEDV (b) AoI>95 Mode CS CS CS or LI LI EFW<p3 CPR>p95 UtA>p95 MCA<p5 <26w Mort. >90% 50% <10% Morb. >90% 50%
71 IUGR Management protocol according to severity stages Stage V IV III II I Follow- up Daily 1-2 d 2/w 1/w Delivery DV(a- ) cctg abn. CTG dec. DV>p95 UV puls REDV (a) AEDV (b) AoI>95 Mode CS CS CS or LI LI EFW<p3 CPR>p95 UtA>p95 MCA<p5 <26w Mort. >90% 50% <10% Morb. >90% 50%
72
73 The main goal in FGR is identification
74 The main goal in FGR is identification Small fetus (EFW<p10) must be divided in:
75 The main goal in FGR is identification Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome)
76 The main goal in FGR is identification Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome) SGA (we don t know, perinatal outcome N, poor long term)
77 The main goal in FGR is identification Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome) SGA (we don t know, perinatal outcome N, poor long term) Early and late-onset FGR (GA 32s) represent two distinct phenotypes of the same disease
78 The main goal in FGR is identification Small fetus (EFW<p10) must be divided in: FGR (placenta, poor perinatal and long-term outcome) SGA (we don t know, perinatal outcome N, poor long term) Early and late-onset FGR (GA 32s) represent two distinct phenotypes of the same disease Clinically, a single stage-based protocol allows optimizing decisions in all cases
79
UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH RESCTRICTION
UPDATE ON DIAGNOSIS AND MANAGEMENT OF FETAL GROWTH RESCTRICTION Eduard Gratacos Servicio de Medicina Maternofetal Hospital Clinic y Hospital Sant Joan de Deu - Universidad de Barcelona www.fetalmedicinebarcelona.org
More informationA (quasi)evidence-based approach to the management of early-onset IUGR
A (quasi)evidence-based approach to the management of early-onset IUGR Eduard Gratacós Barcelona Center for Maternal-Fetal and Neonatal Medicine Hospital Clínic and Hospital Sant Joan de Deu, University
More informationKey issues in (early and late) IUGR
Key issues in (early and late) IUGR Eduard Gratacós Maternal-Fetal Medicine Department, Hospital Clínic, University of Barcelona www.fetalmedicinebarcelona.org (early-onset) IUGR vs SGA: the era of UA
More informationImpact of (early and late) IUGR on neurodevelopment
Impact of (early and late) IUGR on neurodevelopment Eduard Gratacos Maternal-Fetal Medicine Department and Research Center Hospitals Clinic and Sant Joan de Deu - University of Barcelona www.fetalmedicinebarcelona.org
More informationManagement of IUGR Prof. Dr. Acar KOÇ
Management of IUGR Prof. Dr. Acar KOÇ Ankara University School of Medicine Department of OB&GYN Department of Perinatology Definition and Diagnosis: SGA IUGR EFW: < 10th percentile EFW: < 10th percentile
More informationProgramación fetal Evidencias actuales y papel de la nutrición fetal
Programación fetal Evidencias actuales y papel de la nutrición fetal Eduard Gratacos BCNatal Centre de Medicina Maternofetal i Neonatologia de Barcelona Hospital Sant Joan de Déu i Hospital Clínic, Universitat
More informationIUGR AND LONG TERM CV FUNCTION
IUGR AND LONG TERM CV FUNCTION Eduard Gratacós www.fetalmedicinebarcelona.org www.fetalmedicinebarcelona.org/ 1. Fetal growth and cardiovascular function 2. IUGR and cardiac programming 3. Clinical implications
More informationBasic Doppler Assessment of Fetal Distress
Basic Doppler Assessment of Fetal William J. Polzin, M.D. Co-Director, Fetal Care Center of Cincinnati Director, Division of Maternal-Fetal Medicine Good Samaritan Hospital Cincinnati, OH No Relevant Disclosures
More informationDiagnosis and Management of the Early Growth Restricted Fetus
11 th Congress of Maternal Fetal Medicine and Perinatology Society of Turkey Diagnosis and Management of the Early Growth Restricted Fetus Giancarlo Mari, MD, MBA, FACOG, FAIUM Professor and Chair Department
More information39 th Annual Perinatal Conference Vanderbilt University December 6, 2013 IUGR. Diagnosis and Management
39 th Annual Perinatal Conference Vanderbilt University December 6, 2013 IUGR Diagnosis and Management Giancarlo Mari, M.D., M.B.A. Professor and Chair Department of Obstetrics and Gynecology University
More informationselective IUGR II (and III)!
selective IUGR II (and III) Expectant management and Cord Occlusion Eduard Gratacos BCNatal Barcelona Center of Maternal-Fetal and Neonatal Medicine Hospital Clinic and Hospital Sant Joan de Déu, University
More information4/19/2018. St. Cloud Hospital Perinatology Kristin Olson, RDMS, RVT
St. Cloud Hospital Perinatology Kristin Olson, RDMS, RVT Review Fetal Circulation Provide Indications for Umbilical Artery, Middle Cerebral Artery, and Ductus Venosus Doppler studies. Demonstrate normal
More informationFetal cardiovascular parameters for the prediction of postnatal cardiovascular risk in intrauterine growth-restriction?
17 th International Conference on Prenatal Diagnosis and Therapy Lisbon, June 2013 Fetal cardiovascular parameters for the prediction of postnatal cardiovascular risk in intrauterine growth-restriction?
More informationPIAF study: Placental insufficiency and aortic isthmus flow Jean-Claude Fouron, MD
Dear colleagues, I would like to thank you very sincerely for agreeing to participate in our multicentre study on the clinical significance of recording fetal aortic isthmus flow during placental circulatory
More informationThe Fetus: Five Top Do Not Miss Diagnoses. Doppler Ultrasound
The Fetus: Five Top Do Not Miss Diagnoses Doppler Ultrasound Giancarlo Mari, MD, MBA Professor and Chair Department of Obstetrics and Gynecology University of Tennessee Health Science Center Memphis, TN
More informationOptimising your Doppler settings for an accurate PI. Alison McGuinness Mid Yorks Hospitals
Optimising your Doppler settings for an accurate PI Alison McGuinness Mid Yorks Hospitals Applications Both maternal uterine and fetal circulations can be studied with doppler sonography Uterine arteries
More informationCardiovascular fetal programming and remodelling Long term effects of adverse fetal environment on the heart
Cardiovascular fetal programming and remodelling Long term effects of adverse fetal environment on the heart Eduard Gratacos Maternal-Fetal Medicine Department and Research Center Hospital Clinic - University
More informationThe role of Doppler studies in predicting individual intrauterine fetal demise after laser therapy for twin twin transfusion syndrome
Ultrasound Obstet Gynecol 2003; 22: 246 251 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.215 The role of Doppler studies in predicting individual intrauterine fetal
More informationFETAL ECHO IN TWIN PREGNACY: MONOCHORIONIC TWINS DELHI CHILD HEART CENTER & INDRAPRASTHA APOLLO HOSPITAL NEW DELHI
FETAL ECHO IN TWIN PREGNACY: MONOCHORIONIC TWINS DELHI CHILD HEART CENTER & INDRAPRASTHA APOLLO HOSPITAL NEW DELHI Scope of this talk Twin to Twin Transfusion TRAP Sequence Congenital Heart Defects in
More informationCardiac dysfunction by tissue Doppler in early- and late-onset fetal growth restriction
Cardiac dysfunction by tissue Doppler in early- and late-onset fetal growth restriction Montserrat Comas Rovira ADVERTIMENT. La consulta d aquesta tesi queda condicionada a l acceptació de les següents
More informationINTRAUTERINE GROWTH RESTRICTION AND ITS IMPACT ON CARDIAC FUNCTION AND ARTERIAL COMPLIANCE IN THE YOUNG CHILD
INTRAUTERINE GROWTH RESTRICTION AND ITS IMPACT ON CARDIAC FUNCTION AND ARTERIAL COMPLIANCE IN THE YOUNG CHILD Edgar Jaeggi, MD, FRCPC Associate Scientist, RI Fetal Cardiac Program, The Hospital for Sick
More informationFailing right ventricle
Failing right ventricle U. Herberg 1, U. Gembruch 2 1 Pediatric Cardiology, 2 Prenatal Diagnostics and Fetal Therapy, University of Bonn, Germany Prenatal Physiology Right ventricle dominant ventricle
More informationVenous Doppler Evaluation of the Growth-Restricted Fetus
Venous Doppler Evaluation of the Growth-Restricted Fetus Ahmet Alexander Baschat, MD KEYWORDS Fetal growth restriction Doppler Ductus venosus Venous circulation Fetal surveillance Integrated testing The
More informationDoppler changes in the main fetal brain arteries at different stages of hemodynamic adaptation in severe intrauterine growth restriction
Ultrasound Obstet Gynecol 2007; 30: 297 302 Published online 30 July 2007 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.4084 Doppler changes in the main fetal brain arteries at different
More informationAssessment of fetal heart function and rhythm
Assessment of fetal heart function and rhythm The fetal myocardium Early Gestation Myofibrils 30% of myocytes Less sarcoplasmic reticula Late Gestation Myofibrils 60% of myocytes Increased force per unit
More informationValve Disease in the Pregnant Patient
Valve Disease in the Pregnant Patient Julie B. Damp, MD December 6, 2012 VanderbiltHeart.com If single, do not allow marriage. If fertile, do not allow pregnancy. If pregnant, do not allow delivery. If
More informationThe Global Impact of the Intrauterine Experience on Neuropsychlogical Health Prenatal Fetal Brain Remodeling
The Global Impact of the Intrauterine Experience on Neuropsychlogical Health Prenatal Fetal Brain Remodeling Eduard Gratacos Barcelona Center Maternal-Fetal and Neonatal Medicine Hospitals Clinic and Sant
More informationFetal Heart Rate Monitoring Myths and Misperceptions s: Electronic Fetal Heart Rate Monitoring (EFM): Baseline Assumptions.
Can FHR Monitoring Prevent Hypoxic-Ischemic Encephalopathy in the Newborn? Fetal Heart Rate Monitoring Myths and Misperceptions 1. Yes 2. No 72% Tekoa L. King CNM, MPH June 6, 2008 28% Yes No Objectives
More informationFigure removed due to copyright restrictions.
Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz IN SUMMARY HST 071 An Example of a Fetal Heart Rate Tracing Figure removed
More informationMyocardial Velocities, Dynamics of the Septum Primum, and Placental Dysfunction in Fetuses with Growth Restriction
138 Myocardial Velocities, Dynamics of the Septum Primum, and Placental Dysfunction in Fetuses with Growth Restriction Alexandre Antonio Naujorks, MD, PhD, Paulo Zielinsky, MD, PhD, Caroline Klein, MD,
More informationAWHONN Oregon Section 2014
AWHONN Oregon Section 2014 Carol J Harvey, MS, BSN, RNC-OB, C-EFM, CS Northside Hospital Atlanta Cherokee - Forsyth Hypertensive in Pregnancy Carol J Harvey, MS, RNC-OB, C-EFM Clinical Specialist Northside
More informationUpdate on Hypertensive Diseases in Pregnancy
Objectives Update on Hypertensive Diseases in Pregnancy ANNA MCCORMICK, DO MFM FELLOW, MEDICAL COLLEGE OF WISCONSIN At the conclusion of this session, attendees will be able to: Describe the classification
More informationCMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan
CMQCC Preeclampsia Tool Kit: Hypertensive Disorders Across the Lifespan Carol J Harvey, MS, BSN, RNC-OB, C-EFM, CS Northside Hospital Atlanta Cherokee - Forsyth New! Improving Health Care Response to Preeclampsia:
More informationBits and Bobs secondary causes of heart problems. Dr Angela McBrien 9 th September 2017
Bits and Bobs secondary causes of heart problems Dr Angela McBrien 9 th September 2017 Not the heart Dextroposition Heart in the right chest with the apex to the left Often caused by left sided chest mass
More informationOpinion. Technical aspects of aortic isthmus Doppler velocimetry in human fetuses
Ultrasound Obstet Gynecol 2009; 33: 628 633 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.6406 Opinion Technical aspects of aortic isthmus Doppler velocimetry in
More informationResearch Article BehaviouroftheForamenOvaleFlowinFetuseswithIntrauterine Growth Restriction
Hindawi Obstetrics and Gynecology International Volume 2018, Article ID 1496903, 6 pages https://doi.org/10.1155/2018/1496903 Research Article BehaviouroftheForamenOvaleFlowinFetuseswithIntrauterine Growth
More informationFirst Trimester Fetal Echocardiography: Insight Into the Fetal Circulation
First Trimester Fetal Echocardiography: Insight Into the Fetal Circulation Lisa K. Hornberger, MD Fetal & Neonatal Cardiology Program Department of Pediatrics, Division of Cardiology Department of Obstetrics
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationYou admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure
Preeclampsia Case report You admitted a previously healthy nullipara at 36 weeks gestation who presented with new-onset periorbital edema and is found to have blood pressure readings of 150/100 to 155/105
More informationA Computational Model of the Fetal Circulation to Quantify Blood Redistribution in Intrauterine Growth Restriction
A Computational Model of the Fetal Circulation to Quantify Blood Redistribution in Intrauterine Growth Restriction Patricia Garcia-Canadilla 1,2 *, Paula A. Rudenick 3, Fatima Crispi 1, Monica Cruz-Lemini
More informationPrediction of acidemia at birth by Doppler assessment of fetal cerebral transverse sinus in pregnancies with placental insufficiency
Ultrasound Obstet Gynecol 2009; 33: 188 192 Published online 6 October 2008 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.6130 Prediction of acidemia at birth by Doppler assessment
More informationDiabetes in Pregnancy
Disclosure Diabetes in Pregnancy I have no conflicts of interest to disclose Jennifer Krupp, MD Maternal Fetal Medicine St. Marys Hospital/SSM Health Madison, WI Objectives Classification of Diabetes Classifications
More informationFetal cardiac function: what to use and does it make a difference?
17 th International Conference on Prenatal Diagnosis and Therapy Lisbon, June 2013 Fetal cardiac function: what to use and does it make a difference? Fàtima Crispi Department of Maternal-Fetal Medicine,
More informationThe high risk neonate
The high risk neonate Infant classification by gestational (postmenstrual) age Preterm. Less than 37 completed weeks (259 days). Term. Thirty-seven to 416/7 weeks (260-294 days). Post-term. Forty-two weeks
More informationFHR Monitoring: Maternal Fetal Physiology
FHR Monitoring: Maternal Fetal Physiology M. Sean Esplin, MD and Alexandra Eller, MD Maternal Fetal Medicine Intermountain Healthcare University of Utah Health Sciences Center Disclosures I have no financial
More informationSupplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification
Supplemental Digital Content: Definitions Based on the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) Diagnose and Procedures Codes 1. ICD-9-CM definition of
More informationAssessment of Cardiac Dysfunction in the Intrauterine Growth-restricted Fetuses from Pre-eclamptic Mothers
Assessment of Cardiac Dysfunction in the Intrauterine Growth-restricted 10.5005/jp-journals-10009-1346 Fetuses from Pre-eclamptic Mothers Original Article Assessment of Cardiac Dysfunction in the Intrauterine
More informationCase Report Right Ventricular Outflow Tract Obstruction in Monochorionic Twins with Selective Intrauterine Growth Restriction
Case Reports in Pediatrics Volume 2012, Article ID 426825, 4 pages doi:10.1155/2012/426825 Case Report Right Ventricular Outflow Tract Obstruction in Monochorionic Twins with Selective Intrauterine Growth
More informationCongenital heart disease in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery
Chapter 10 Congenital heart disease in twin-to-twin transfusion syndrome treated with fetoscopic laser surgery Enrico Lopriore MD Regina Bökenkamp MD Marry Rijlaarsdam MD Marieke Sueters MD Frank PHA Vandenbussche
More informationMonochorionic Twin with Selective Intrauterine Growth Restriction
R E V I E W A R T I C L E Monochorionic Twin with Selective Intrauterine Growth Restriction Yao-Lung Chang* A monochorionic twin pregnancy with selective intrauterine growth restriction (IUGR) of one twin
More informationMaternal and Fetal Physiology
Background Maternal and Fetal Physiology Anderson Lo, DO Fellow, Maternal-Fetal Medicine Wayne State University School of Medicine SEMCME Fetal Assessment Course July 20, 2018 Oxygen pathway Mother Placenta
More informationHYPOXIC ISCHEMIC ENCEPHALOPATHY AND THE OBSTETRICIAN
HYPOXIC ISCHEMIC ENCEPHALOPATHY AND THE OBSTETRICIAN DISCLOSURE I have nothing to disclose and have no real or potential conflicts with this presentation and its content. Michael P. Nageotte, M.D. CASE:
More information5/29/2015. Disclosures. Background. Objectives. The authors have no financial relationships to disclose or Conflicts of Interest (COIs) to resolve.
Disclosures EARLY MARKERS OF NEURODEVELOPMENTAL OUTCOME IN CONGENITAL HEART DISEASE Ismée A. Williams, MD, MS Assistant Professor of Pediatrics Columbia University Department of Pediatrics Division of
More informationDoppler assessment of fetal aortic isthmus blood flow in two different sonographic planes during the second half of gestation
Ultrasound Obstet Gynecol 2005; 26: 170 174 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.1955 Doppler assessment of fetal aortic isthmus blood flow in two different
More informationCOPYRIGHTED MATERIAL. The fetal circulation CHAPTER 1. Postnatal circulation
1 CHAPTER 1 The fetal circulation The circulation in the fetus differs from that in the adult. Knowledge of the course and distribution of the fetal circulation is important to our understanding of the
More informationThe cerebroplacental Doppler ratio predicts postnatal outcome in fetuses with congenital heart block
ORIGINAL ARTICLE The cerebroplacental Doppler ratio predicts postnatal outcome in fetuses with congenital heart block GA Fleming 1, A Bircher 2, A Kavanaugh-McHugh 1 and MR Liske 1 (2008) 28, 791 796 r
More informationInfants with intrauterine growth restriction
Research www.ajog.org OBSTETRICS Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction Anne-Karen von Beckerath; Martina Kollmann, MD; Christa
More informationAnatomy & Physiology
1 Anatomy & Physiology Heart is divided into four chambers, two atrias & two ventricles. Atrioventricular valves (tricuspid & mitral) separate the atria from ventricles. they open & close to control flow
More informationPregnancies complicated by diabetes. Marina Mickleson Nurse Practitioner Midwife CDE
Pregnancies complicated by diabetes Marina Mickleson Nurse Practitioner Midwife CDE Two types Pre gestational Gestational diabetes Both types are on the increase Pre conception work up is imperative for
More informationHypoglycaemia of the neonate. Dr. L.G. Lloyd Dept. Paediatrics
Hypoglycaemia of the neonate Dr. L.G. Lloyd Dept. Paediatrics Why is glucose important? It provides 60-70% of energy needs Utilization obligatory by red blood cells, brain and kidney as major source of
More informationFetal Cardiac Function and Venous Circulation - Experiences with Velocity Vector Imaging
Fetal Cardiac Function and Venous Circulation - Experiences with Velocity Vector Imaging Dahlbäck, Charlotte Published: 2015-01-01 Link to publication Citation for published version (APA): Dahlbäck, C.
More informationCLINICAL AUDIT SUMMARY CLINICAL AUDIT SUMMARY. Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland
Regional Virology Issue Date: 08/09/14 Page(s): Page 1 of 6 1.0 Name of audit Diagnosis and Recognition of Congenital Cytomegalovirus in Northern Ireland 2.0 Personnel involved Peter Coyle, Han Lu, Daryl
More informationBased on 2014 SOGC Guidelines
Based on 2014 SOGC Guidelines 22nd Edition 2015 1 ICH + gestational hypertension by far the biggest cause of direct maternal deaths New stats coming in 2013 OCR 22nd Edition 2015 2 Diastolic 90 mmhg is
More informationShock is defined as a state of cellular and tissue hypoxia due to : reduced oxygen delivery and/or increased oxygen consumption or inadequate oxygen
Shock is defined as a state of cellular and tissue hypoxia due to : reduced oxygen delivery and/or increased oxygen consumption or inadequate oxygen utilization The effects of shock are initially reversible
More informationDoppler Echocardiography in the Diagnosis and Management of Persistent Fetal Arrhythmias
1386 JACC Vol 7. No 6 June 19X6 I3Xh-91 Doppler Echocardiography in the Diagnosis and Management of Persistent Fetal Arrhythmias JANETTE F. STRASBURGER, MD, JAMES C. HUHTA, MD, FACC, ROBERT J. CARPENTER,
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More informationEditorial. Color and pulsed Doppler in fetal echocardiography A. ABUHAMAD
Ultrasound Obstet Gynecol 2004; 24: 1 9 Published online in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.1096 Editorial Color and pulsed Doppler in fetal echocardiography A. ABUHAMAD
More informationClinical Study Postnatal Growth in a Cohort of Sardinian Intrauterine Growth-Restricted Infants
Hindawi BioMed Research International Volume 2017, Article ID 9382083, 5 pages https://doi.org/10.1155/2017/9382083 Clinical Study Postnatal Growth in a Cohort of Sardinian Intrauterine Growth-Restricted
More informationNo conflict of interest to report
Ultrasound Findings in Fetal Infection No conflict of interest to report Kim A. Boggess MD Ob Gyn UNC at Chapel Hill Learning Objectives At conclusion, participants will Identify maternal infections that
More informationFetal congestive heart failure *
Seminars in Fetal & Neonatal Medicine (2005) 10, 542e552 www.elsevierhealth.com/journals/siny Fetal congestive heart failure * James C. Huhta* USF College of Medicine, St. Petersburg, FL, USA KEYWORDS
More informationMagnetic Resonance Imaging of the fetus
Magnetic Resonance Imaging of the fetus Mary A Rutherford Perinatal Imaging Group, MRC Clinical Sciences Centre Imperial College m.rutherford@imperial.ac.uk The Moonbeam Trust Overview Practicalities and
More informationClinical features. Abnormal vasculogenesis and angiogenesis and releasing of antiangiogenic
Clinical features Abnormal vasculogenesis and angiogenesis and releasing of antiangiogenic factors results in Vasospasm Endothelial dysfunction Etiology of various clinical signs and symptoms So, Preeclampsia
More informationDiabetes in Pregnancy. L.Sekhavat MD
Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes
More informationC V NAME: MEDHAT YEHIA MOHAMED ANWAR MARIATAL SATATUS : MARRIED WITH 3 CHILDREN
C V NAME: MEDHAT YEHIA MOHAMED ANWAR DATE OF BIRTH : 24/8/1951 PLACE OF BIRTH : CAIRO, EGYPT MARIATAL SATATUS : MARRIED WITH 3 CHILDREN ADDRESS : 264 ABDEL SALAM AREF FACING SARAYA TRAM STATION, FLAT 403
More informationETIOLOGY AND PATHOGENESIS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY
ETIOLOGY AND PATHOGENESIS OF HYPOXIC-ISCHEMIC ENCEPHALOPATHY HYPOXIC-ISCHEMIC ENCEPHALOPATHY Hypoxic-İschemic Encephalopathy Encephalopathy due to hypoxic-ischemic injury [Hypoxic-ischemic encephalopathy
More informationPregnancy outcomes in women after an arterial switch operation for transposition of the great arteries
Pregnancy outcomes in women after an arterial switch operation for transposition of the great arteries Department of Obstetrics and Gynecology 1) Department of Pediatrics 2) National Cerebral and Cardiovascular
More informationAssessment of foetal cardiac function by myocardial tissue doppler in foetal growth restriction
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Basu B et al. Int J Reprod Contracept Obstet Gynecol. 2017 Mar;6(3):1045-1051 www.ijrcog.org pissn 2320-1770 eissn 2320-1789
More informationStudy of the role of low dose magnesium Sulphate in Hypertensive Disorders of Pregnancy 1 2
ORIGINAL ARTICLE J Pub Health Med Res 2015;3(2):31-37 Study of the role of low dose magnesium Sulphate in Hypertensive Disorders of Pregnancy 1 2 Shubha C.R. Vailaya, Naveena Kumari M. 1 Chief Consultant
More informationShould infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants?
Should infants with perinatal thrombosis be screened for thrombophilia and treated by anticoagulants? Shoshana Revel-Vilk, MD MSc Pediatric Hematology Center, Pediatric Hematology/Oncology Department,
More informationEarly Childhood Neurodevelopment After Intrauterine Growth Restriction: A Systematic Review
Early Childhood Neurodevelopment After Intrauterine Growth Restriction: A Systematic Review Terri A. Levine, MSc a, Ruth E. Grunau, PhD a,b,c, Fionnuala M. McAuliffe, FRCPI, FRCOG, MD d, RagaMallika Pinnamaneni,
More informationThe short-term effect of nifedipine tocolysis on placental, fetal cerebral and atrioventricular Doppler waveforms
Ultrasound Obstet Gynecol 004; 4: 761 765 Published online 6 October 004 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.100/uog.1770 The short-term effect of nifedipine tocolysis on placental,
More informationCONTROL OF BLOOD PRESSURE IN PREGNANCY: HOW HIGH IS TOO HIGH? EVELYNE REY, CHU Ste-Justine, Montreal
CONTROL OF BLOOD PRESSURE IN PREGNANCY: HOW HIGH IS TOO HIGH? EVELYNE REY, CHU Ste-Justine, Montreal CONFLICTS OF INTEREST $: None Others: Canadian guidelines, CHIPS CSIM2015 2 LEARNING OBJECTIVES New
More informationPlacental Transport in Pathologic Pregnancies
Note: for non-commercial purposes only Placental Transport in Pathologic Pregnancies Gernot Desoye Clinic of Obstetrics and Gynaecology Medical University, Graz Most Common Pregnancy Pathologies Diabetes
More informationPRE GESTATIONAL DIABETES. Conflicts
PRE GESTATIONAL DIABETES Christopher Goodier, MD Assistant Professor, Maternal Fetal Medicine Medical University of South Carolina Conflicts I have no relevant disclosures or conflict of interest with
More informationCardiac Intervention in Fetus. Gyeong-hee Yoo, M.D. Department of Pediatrics Soonchunhyang University Cheonan Hospital
10 1111 Cardiac Intervention in Fetus Gyeong-hee Yoo, M.D. Department of Pediatrics Soonchunhyang University Cheonan Hospital Fetal echocardiography Serial f/u intrauterine course of disease Cardiac anomaly
More informationDifficulties at Birth: Long Term Developmental Outcomes
Difficulties at Birth: Long Term Developmental Outcomes Alan D. Bedrick MD Division of Neonatology and Developmental Biology Department of Pediatrics University of Arizona Tucson, Arizona DISCLOSURE I
More informationNeonatal Hypoglycemia. Presented By : Kamlah Olaimat 25\7\2010
Neonatal Hypoglycemia Presented By : Kamlah Olaimat 25\7\2010 Definition The S.T.A.B.L.E. Program defines hypoglycemia as: Glucose delivery or availability is inadequate to meet glucose demand (Karlsen,
More informationGUIDELINE PHYSIOLOGY OF BIRTH ASPHYXIA
GUIDELINE PHYSIOLOGY OF BIRTH ASPHYXIA The newborn is not an adult, nor a child. In people of all ages, death can occur from a failure of breathing and / or circulation. The interventions required to aid
More informationORIGINAL ARTICLES Association of Hyperuricaemia with Perinatal Outcome in Pregnancy Induced Hypertension
ORIGINAL ARTICLES Association of Hyperuricaemia with Perinatal Outcome in Pregnancy Induced Hypertension S AKTER a, S SULTANA b, SR DABEE c Summary: The high serum uric acid concentration correlates with
More informationCorrelation analysis of ductus venosus velocity indices and fetal cardiac function
Ultrasound Obstet Gynecol 2014; 43: 515 519 Published online 3 April 2014 in Wiley Online Library (wileyonlinelibrary.com). DOI: 10.1002/uog.13242 Correlation analysis of ductus venosus velocity indices
More informationHypoglycemia. Objectives. Glucose Metabolism
Hypoglycemia Instructor: Janet Mendis, MSN, RNC-NIC, CNS Outline: Janet Mendis, MSN, RNC-NIC, CNS Summer Morgan, MSN, RNC-NIC, CPNP UC San Diego Health System Objectives State the blood glucose level at
More informationPhysiologic Based Management of Circulatory Shock Kuwait 2018
Physiologic Based Management of Circulatory Shock Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal Echocardiography, Point of Care and Hemodynamics Program Staff Neonatologist
More informationInfant Of Diabetic Mother(IDM)
Infant Of Diabetic Mother(IDM) Sangram Satish Magar 1, Sanskriti Mirashi 2 1. M.D. Sch.(Kaumarbhrutya-Balrog) 2.Guide (Kaumarbhrutya-Balrog), L.R.P.Medical college,islampur,tal- Walwa, dist- Sangli, Maharashtra,
More informationCHRONIC HYPOXEMIA AND FETAL HEMODYNAMICS
REVIEW ARTICLES CHRONIC HYPOXEMIA AND FETAL HEMODYNAMICS Graziano Clerici, Maria Cristina Spataru, Gian Carlo Di Renzo REZUMAT Hipoxemia fetală este rezultatul unor procese fiziopatologice feto-materne
More informationDurlaza. Durlaza (aspirin) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.85.13 Subject: Durlaza Page: 1 of 4 Last Review Date: September 15, 2016 Durlaza Description Durlaza
More informationPaediatrica Indonesiana. Echocardiographic patterns in asphyxiated neonates. Maswin Masyhur, Idham Amir, Sukman Tulus Putra, Alan Roland Tumbelaka
Paediatrica Indonesiana VOLUME 49 July NUMBER 4 Original Article Echocardiographic patterns in asphyxiated neonates Maswin Masyhur, Idham Amir, Sukman Tulus Putra, Alan Roland Tumbelaka Abstract Background
More informationPediatric Neurointervention: Vein of Galen Malformations
Pediatric Neurointervention: Vein of Galen Malformations Johanna T. Fifi, M.D. Assistant Professor of Neurology, Neurosurgery, and Radiology Icahn School of Medicine at Mount Sinai November 9 th, 2014
More informationStudy of renal functions in neonatal asphyxia
Original article: Study of renal functions in neonatal asphyxia *Dr. D.Y.Shrikhande, **Dr. Vivek Singh, **Dr. Amit Garg *Professor and Head, **Senior Resident Department of Pediatrics, Pravara Institute
More informationSWISS SOCIETY OF NEONATOLOGY. Prenatal closure of the ductus arteriosus
SWISS SOCIETY OF NEONATOLOGY Prenatal closure of the ductus arteriosus March 2007 Leone A, Fasnacht M, Beinder E, Arlettaz R, Neonatal Intensive Care Unit (LA, AR), University Hospital Zurich, Cardiology
More informationDoppler Sonography in Pregnancies Complicated with Pregestational Diabetes Mellitus
Chapter 21 Doppler Sonography in Pregnancies Complicated with Pregestational Diabetes Mellitus Dev Maulik, Genevieve Sicuranza, Andrzej Lysikiewicz, Reinaldo Figueroa Introduction During the past few decades,
More information